Skip to content
10-Q

Quarterly Report

NU-MED PLUS, INC. NUMD

0001548123-23-000160

← back to feed
Filed
Nov 1, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 1, 2023 81.35M sh
Current Liabilities Q3 2023 · Sep 30, 2023 $145.7K
Current Liabilities Q3 2023 · Dec 31, 2022 $142.57K
Total Liabilities Q3 2023 · Sep 30, 2023 $145.7K
Total Liabilities Q3 2023 · Dec 31, 2022 $142.57K
Current Assets Q3 2023 · Sep 30, 2023 $13.75K
Current Assets Q3 2023 · Dec 31, 2022 $79.55K
Total Assets Q3 2023 · Sep 30, 2023 $13.75K
Total Assets Q3 2023 · Dec 31, 2022 $79.55K
Shares Diluted Q3 2023 · Sep 30, 2022 79.74M sh
Shares Diluted Q3 2023 · Sep 30, 2022 79.48M sh
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$14.05K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$270.13K
Stockholders Equity Q3 2023 · Jun 30, 2022 −$247.08K
Stockholders Equity Q3 2023 · Mar 31, 2022 −$189.01K
Stockholders Equity Q3 2023 · Dec 31, 2021 −$132.36K
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Sga Expense Q3 2023 · Sep 30, 2022 $5.7K
Sga Expense Q3 2023 · Sep 30, 2022 $19.9K
Net Income Q3 2023 · Sep 30, 2022 −$58.05K
Net Income Q3 2023 · Sep 30, 2022 −$172.77K
Net Income Q3 2023 · Jun 30, 2022 −$58.07K
Net Income Q3 2023 · Mar 31, 2022 −$56.65K
Operating Income Q3 2023 · Sep 30, 2022 −$58.05K
Operating Income Q3 2023 · Sep 30, 2022 −$175.77K